455 Share Price Performance
HK$0.097
-0.07 (-42.26%)
Price HK$0.097
Share Pricen/a
Tianda Pharmaceuticals Limited's (HKG:455) Revenues Are Not Doing Enough For Some Investors
Dec 29
Tianda Pharmaceuticals Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
455 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Tianda Pharmaceuticals Limited Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- -0.033
- 41.28%
- -21.67%
- 27.2%
About 455
- Founded
- 1992
- Employees
- 624
- CEO
- WebsiteView website
Tianda Pharmaceuticals Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. It operates through the Chinese Medicine, Pharmaceuticals and Medical Technologies, and Medical and Healthcare Services segments. The company offers Chinese herbal medicine, Chinese medicine decoction pieces, Chinese medicine products, and Chinese medicine clinical services. It also produces pharmaceutical products focusing on cardiovascular and cerebrovascular chronic diseases, respiratory infections, and pediatric diseases. In addition, the company trades agricultural by-products. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.
